Login / Signup

The Efficacy and Safety of the Shouzu Ning Decoction Treatment Versus Halometasone Plus Celecoxib Treatment in Patients With Grade 2 HFSR: A Randomized Clinical Trial.

Liumei ShouTianyu ShaoJialu ChenYao ZhangQi-Jin Shu
Published in: Integrative cancer therapies (2023)
Chinese Clinical Trial Registry, ChiCTR1900027518. Registered on 17 Nov 2019.
Keyphrases
  • clinical trial
  • randomized controlled trial
  • phase ii